International Biotechnology Trust (IBT)

Category Sector Equity Biotechnology
star-filledstar-filledstar-filledstar-filled
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Sell

684.00p

Buy

688.00p

arrow-up0.00p (+0.00%)

Discount/Premium

-12.13%

Estimated NAV

778.459p

Prices updated at 05 Nov 2024, 12:56 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
FTSE All-Share
arrow-down-0.1%
LSE
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Most recent dividend payment

0.145
Cash Dividend
25 Jul 2024
03 Jul 2024
26 Jul 2024
23 Aug 2024
Dividend cover-

Income only yield

No data available

Dividend per share

Income only yield data table

YearIncome only yield
2024-
2023-
2022-
2021-
2020-
2019-
2018-
2017-

Dividend per share data table

YearDividend per share
20240.1450
20230.2810
20220.2970
20210.2990
20200.2660
20190.2640
20180.4100
20170.2300


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2024 Morningstar. All rights reserved.